Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Hemorrhagic thrombocythemia"'
Publikováno v:
Journal of Hematology & Thromboembolic Diseases.
A 9-year-old Caucasian boy presented in 1994 with severe headache, attacks of migraine, aggressive behavior and minor bleeding symptoms. Initial abnormal laboratory data were a platelet count of 1596 × 109/L and slight splenomegaly on echogram. Low-
Autor:
Claire N. Harrison, Steven Okoli
Publikováno v:
Journal of blood medicine
In 1934, Epstein and Goedel used the term hemorrhagic thrombocythemia to describe a disorder characterized by permanent elevation of a platelet count to more than three times normal, hyperplasia of megakaryocytes, and the tendency for venous thrombos
Autor:
Unto Uotila
Publikováno v:
Acta Medica Scandinavica. 95:136-150
Autor:
Jan Jacques Michiels
Publikováno v:
Journal of Hematology & Thromboembolic Diseases.
We analysed between 1908 and 1985 of two hundred cases of thrombocythemia from the literature between 1908 and 1985. Erythromelalgic, acrocyanotic ischemia and digital gangrene, cerebral or coronary ischemic events (erythromelalgic thrombotic thrombo
Autor:
Jan Jacques Michiels
Publikováno v:
Journal of Hematology & Thromboembolic Diseases.
Aspirin responsive erythromelalgia is the presenting symptom of thrombocythemia in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Skin punch biopsies taken from the affected areas of erythromelalgia and acrocyanotic compicat
Autor:
Scott Murphy
Publikováno v:
Thrombosis and Haemostasis. 78:622-626
With these uncertainties, which patients with ET and PV should receive myelosuppressive therapy and accept its possible risks? Remembering the generalization from the literature that most patients with ET who are to have a catastrophic thrombosis eit
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 23(5)
Essential thrombocythemia (ET) is a risk factor for ischemic stroke and, far more rarely, hemorrhage. We report the case of an untreated 32-year-old woman with a history of JAK2 V617F–positive ET with cerebellar and subarachnoid hemorrhages without
Autor:
Jan Jacques Michiels
Publikováno v:
Leukemia & Lymphoma. 22:1-14
According to strict morphological, biochemical and cytogenetic criteria Philadelphia chromosome positive essential thrombocythemia and chronic granulocytic leukemia constitute a separate malignant and individual disease entity, whereas Philadelphia c
Autor:
Christine S. Hunter, Gregory G. Marino, Michael Anderson, George A. Luiken, Frederick E. Millard, Martin J. Edelman, Michael P. Kosty
Publikováno v:
American Journal of Hematology. 33:27-31
Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by isolated overproduction of platelets, thrombohemorrhagic complications, and a median age of 50-60. When it occurs in younger patients, the incidence of complications has
Autor:
J. J. Michiels
Publikováno v:
27. Hämophilie-Symposion Hamburg 1996 ISBN: 9783540629153
Essential thrombocythemia and thrombocythemia in polycythemia vera manifest itself in two clinical pictures: thrombotic thrombocythemia and hemorrhagic thrombocythemia. The broad spectrum of microcirculatory events including erythromelalgia and neuro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6a3863ff2bfa487e2a7815c1fba68d3
https://doi.org/10.1007/978-3-642-80403-8_63
https://doi.org/10.1007/978-3-642-80403-8_63